NOBLEOAK LIFE LIMITED (NOL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

NOL - NOBLEOAK LIFE LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.65

12 Apr
2024

0.020

OPEN

$1.62

1.23%

HIGH

$1.65

18,636

LOW

$1.62

TARGET
$2.85 72.7% upside
OTHER COMPANIES IN THE SAME SECTOR
AUB . CVW . FCL . GDG . HLI . IAG . MPL . NHF . PSI . QBE . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
NOL: 1
Title FY22
Actual
FY23
Actual
FY24
Forecast
FY25
Forecast
EPS (cps) xxx N/A 18.6 xxx
DPS (cps) xxx N/A 0.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 8.9 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx9.3
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx90.9 M
Book Value Per Share xxxxxxxxxxxxxxx139.4
Net Operating Cash Flow xxxxxxxxxxxxxxx130.1 M
Net Profit Margin xxxxxxxxxxxxxxx8.79 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx6.91 %
Return on Invested Capital xxxxxxxxxxxxxxx6.75 %
Return on Assets xxxxxxxxxxxxxxx4.29 %
Return on Equity xxxxxxxxxxxxxxx6.91 %
Return on Total Capital xxxxxxxxxxxxxxx11.62 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx129.8 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx5 M
Total Debt xxxxxxxxxxxxxxx6 M
Goodwill - Gross xxxxxxxxxxxxxxx0 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx50 M
Price To Book Value xxxxxxxxxxxxxxx1.31

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx0.5 M
Capex % of Sales xxxxxxxxxxxxxxx0.52 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx59 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx178 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Shaw and Partners

29/02/2024

1

Buy

$2.85

72.73%

NobleOak Life delivered first half results that revealed it continues to win market share. FY24 guidance is for growth of 15-20% and Shaw and Partners expects the lower end of the range, maintaining relatively conservative forecasts beyond FY24 which provide plenty of room for upside.

Forecasts reflect the new accounting standards while the investment thesis is maintained. Insurance margins remain strong, with the net claims experience better than the broker expected. Buy rating retained. Target is unchanged at $2.85.

FORECAST
Shaw and Partners forecasts a full year FY24 dividend of 0.00 cents and EPS of 18.60 cents.
Shaw and Partners forecasts a full year FY25 dividend of 0.00 cents and EPS of 20.20 cents.

NOL STOCK CHART